MomGuard NIPT Test
These resources detail the MomGuard NIPT (Non-Invasive Prenatal Test) technology developed and administered by LabGenomics, a South Korea-based expert laboratory.
This podcast episode was prepared with AI assistance. The expressions in the content may occasionally have shortcomings or linguistic errors. The information here is for general informational purposes only; it does not constitute a diagnosis or treatment recommendation. For any evaluation and decision regarding your health condition, please consult your physician or Omega Genetik Diagnostic Evaluation Center.
About the Episode
These resources detail the MomGuard NIPT (Non-Invasive Prenatal Test) technology developed and administered by LabGenomics, a South Korea-based expert laboratory. This test, which can be performed with just a blood sample in the early stages of pregnancy, can detect chromosomal anomalies in the baby with a very high accuracy rate of 99.8%. The system's reliability is based on advanced next-generation sequencing (NGS) techniques performed using Illumina infrastructure and Hamilton automation devices. The presented documents highlight the test's advantages such as fast results, no miscarriage risk, and suitability for all types of pregnancies, while also explaining the strict quality control processes applied for sample safety. Additionally, technical details such as video recording systems and proprietary algorithms used by the laboratory, which has experience with over half a million tests, are shared. In summary, these documents provide a comprehensive overview of the safe, scientific, and sensitive nature of the MomGuard test for expectant mothers and professionals.